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For almost two decades, it has been postulated that calcium-
activated Cl channels (CaCCs) play a role in airway epithelial
Cl secretion, but until recently, the molecular identity of the
airway CaCC(s) was unknown. Recent studies have unequivo-
cally identified TMEM16A as a glandular epithelial CaCC. We
have studied the airway bioelectrics of neonatal mice homozy-
gous for a null allele of Tmem16a (Tmem16a/) to investigate
the role of this channel in Cl secretion in airway surface epi-
thelium. When compared with wild-type tracheas, the
Tmem16a/ tracheas exhibited a >60% reduction in purino-
ceptor (UTP)-regulated CaCC activity. Other members of the
Tmem16genefamily, includingTmem16fandTmem16k,werealso
detectedby reverse transcription-PCR inneonatal tracheal epithe-
lium, suggesting that other familymembers couldbe considered as
contributing to thesmall residualUTPresponse.TMEM16A,how-
ever, appeared to contribute little to unstimulated Cl secretion,
whereas studies with cystic fibrosis transmembrane conductance
regulator (CFTR)-deficient mice and wild-type littermates
revealed that unstimulated Cl secretion reflected 50% CFTR
activity and 50% non-Tmem16a activity. Interestingly, the tra-
cheas of both the Tmem16a/ and the CFTR/ mice exhibited
similar congenital cartilaginousdefects thatmay reflect a common
Cl secretory defect mediated by the molecularly distinct Cl
channels. Importantly, the residualCaCCactivity inTmem16a/
mice appeared inadequate for normal airway hydration because
Tmem16a/ tracheas exhibited significant, neonatal, lumenal
mucusaccumulation.Ourdatasuggest thatTMEM16ACaCC-me-
diated Cl secretion appears to be necessary for normal airway
surface liquid homeostasis.
The disease cystic fibrosis (CF)2 occurs due to the loss of the
epithelial cAMP-mediated Cl channel CFTR. The calcium-
activated Cl conductance (CaCC) channel has often been
referred to as the “alternate” Cl channel (1) because it may
serve to protect tissues that lack CFTR by providing a parallel
route for Cl secretion across the apical membrane. Thus,
identification and characterization of CaCC and the gene that
encodes this activity has become of critical importance to iden-
tify a possible therapeutic target for CF disease. Despite the
important contribution of CaCC in regulated ion and fluid
transport of the airway, this function has not until recently been
assigned to a known gene.
The anoctamin/TMEM16 family of genes has been proposed
to encode CaCC proteins (2–4). Three independent laborato-
ries identified TMEM16A, also known as Ano1, as a CaCC and
suggested a role for TMEM16A in glandular (mammary, sali-
vary) secretion. Yang et al. (4) used a bioinformatic approach to
identify TMEM16A and then confirmed CaCC function by
expression cloning in HEK293 cells and small interfering RNA
knockdown in mouse salivary glands. Caputo et al. (2) utilized
the observation that chronic interleukin-4 stimulation of air-
way epithelial cells resulted in increased CaCC activity to iden-
tify TMEM16A by microarray analysis and demonstrated that
TMEM16A also showed an ion channel activation, inhibition,
and anion selectivity profile consistent with native airway
CaCCs. Lastly, Schroeder et al. (3) used an elegant expression
cloning approach to identify the Xenopus ortholog of TMEM16A
and characterize its function and expression, i.e. in glands (mam-
mary, salivary). Collectively, TMEM16A clearly demonstrates
many ifnot all of thecharacteristics requiredof a candidategene to
produce airway epithelial CaCC. Interestingly, mice that lack
Tmem16a (Tmem16a/) were generated prior to identification
of TMEM16A function. These mice demonstrated failure to
thrive, died shortly after birth, and exhibited a severe malforma-
tion of the tracheal cartilage rings (5).
In contrast to glands, superficial airway epithelial cells finely
balance transepithelial ion transport to maintain the thin layer
of liquid on airway surfaces essential for mucociliary clearance
(MCC) (6). This balance is achieved via the opposing activities
of the epithelial Na channel (ENaC), primarily responsible for
Na absorption (and osmotically coupled liquid absorption)
versus at least two apical membrane Cl channels, CFTR
(responsive to cAMP signaling) and CaCC, responsible for
Ca2 mediated Cl secretion. The identification of TMEM16A
as mediating CaCC activity now provides an opportunity to
better understand the fine tuning that produces appropriate
airway surface liquid (ASL) volume and MCC.
In the present study, we utilized tracheas resected from new-
born Tmem16a/, /, and wild-type (WT) mice to investi-
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gate the contribution of TMEM16A to unstimulated andCa2-
regulated Cl secretion. Regions of tracheas devoid of
submucosal glands were selected for study to characterize the
role of TMEM16A in superficial epithelial Cl secretion.
Because tracheas from Tmem16a/ mice exhibited some
residual CaCC activity, mRNA analysis was performed to iden-
tify other TMEM family members that might function as
CaCCs in the neonatal trachea. We also compared the tracheal
bioelectric properties of neonatal CF tracheas with those of
Tmem16a/ tracheas to elucidate the relative roles of each
Cl channel in airway Cl secretion and mucus clearance.
Finally, we compared the histology and morphology of the tra-
cheas from Tmem16a/ and Cftr/ mice in an attempt to
link defective Cl secretion to tracheal cartilaginous defects
and the mode of early postnatal death characteristic of these
animals.
EXPERIMENTAL PROCEDURES
Tracheal Bioelectric Properties—All pups were removed
from their mothers within 12–48 h after birth and studied
immediately. Both gene mutations (Tmem16a; see Ref. 5 for
details) andCftr (cftrtm1unc) were on amixed strain background.
There was no significant difference in the bodymass among the
three genotypes of theTmem16amice or theCftr/ (CF)mice
and theirWT littermates at this early age (data not shown). For
the CF line, pups / for CFTR are considered to be WT
because we have not detected phenotypic differences in airway
bioelectric properties between tracheas / versus / for
CFTR (data not shown). The pups for theUssing chamber study
were killed by an overdose of ketamine/xylazine, and the tra-
cheas were immediately removed, mounted on an Ussing
chamber, and studied. All preparations were bathed bilaterally
in Krebs bicarbonate ringer, as reported previously (7). The
non-stimulated short circuit current (Isc) was measured when
the Isc stabilized (30 min after mounting). The tracheas were
then exposed cumulatively to a Na transport blocker (amilo-
ride, 104 M, lumenal), UTP (104 M, lumenal), forskolin (105
M, lumenal), and a blocker of Cl secretion (bumetanide, 104
M, basolateral), and bioelectric properties were measured after
each drug addition. The investigators conducting the experi-
ments and calculating the data were blinded as to genotype.
Animals were routinely genotyped by PCR using tail DNA col-
lected when the pups were euthanized. Genotyping was as
described (5).
RNA Isolation—For isolation of tracheal epithelial RNA, 3–4
wild-type (ICR strain) newborn mice were euthanized by
decapitation, and tracheas were dissected in ice-cold phos-
phate-buffered saline. Tracheas were cut into halves at the level
of the sixth cartilage ring to obtain distal and proximal halves
and incubated in 10 units/mlDispase (BDBiosciences, San Jose,
CA) for 25 min at room temperature. The epithelium was
peeled from the mesenchyme using fine forceps. Epithelia and
mesenchyme from proximal and distal trachea were collected
in phosphate-buffered saline on ice before quick freezing in
liquid nitrogen and storage at80 °C until RNA isolation. RNA
was isolated according to the manufacturer’s specifications
using either the RNeasy kit (for adult trachea/brain/eye) or the
RNeasy Plus kit (for newborn epithelium/mesenchyme) (Qia-
gen, Germantown,MD). Other RNA samples (adult lung) were
purchased from Ambion. RNA was analyzed for concentration
and quality on the NanoDrop spectrophotometer and Agilent
2100 bioanalyzer. 200 ng of total RNA was used to synthesize
cDNA using SuperScript III reverse transcriptase and theman-
ufacturer’s protocol (Invitrogen). For adult samples, 100 ng of
cDNA was used in each PCR reaction; 200 ng was used for
newborn tracheal samples. Primers were ordered specifically to
cross introns and are as follows (accession numbers used are
given in parentheses): Tmem16a (NM_178642), forward, 5-
GGCTTTGTCACCCTGTTTGT-3, reverse, 5-GAGAGCGT-
GTGATTGACGAA-3; Tmem16b (NM_153589), forward, 5-
GGCAAGTTCTCCGTCATCAT-3, reverse, 5-AACCTCC-
TGGTCGAACTGTG-3; Tmem16f (NM_175344), forward,
5-ATGGGACACCGTTGAGCTAC-3, reverse, 5-TCAGG-
TACTTCTGGATCGGG-3; Tmem16j (NM_178381), for-
ward, 5-TGAAGGATGGGGTTTTTGAG-3, reverse, 5-
CCAAGAGGGCACATGAAGAT-3; Tmem16k (NM_133979),
forward, 5-TGCAGTTTGGCTATGTGAGC-3, reverse, 5-
GGCCAGTTTCTGTTGGATGT-3. For RT-PCR, ImmoMix
(Bioline, Taunton, MA) was used according to recommended
conditions with a 25-l volume in an ABI thermocycler.
Cycling conditions were as follows: 95 °C for 10 min hot start
followed by 35 cycles of 95° 30 s, 55 °C for 30 s, 72° for 30 s,
ending with 7 min at 72 °C and a 4 °C hold. All RT-PCR reac-
tions included no reverse-transcriptase controls, which were
negative (not shown), and all products were cloned from posi-
tive control tissues and sequenced to confirm product identity.
Histology—Preparations removed from Ussing chambers
were fixed to examine histologically for the presence of submu-
cosal glands. After removal from the chambers, these small
specimens were stained with tissue marking dye (Triange Bio-
medical Sciences) for easy visualization and then processed. For
general histology, tracheas from newborn mouse pups, eutha-
nized by an overdose of ketamine/xylazine, were fixed in situ in
neutral buffered formalin, processed, and stained with Alcian
blue periodic acid Schiff (AB-PAS) or hematoxylin and eosin.
For histology of the CF tracheas, we utilized F508 CF pups
(cftrtm1kth). Note that the histological defects and bioelectrics of
the two CFTR mutations appear identical (8).3
Statistics—When more than two groups were compared
(Tmem16a mice), a one-way analysis of variance was used.
When only two groups were being compared (CF versusWT), a
Student’s t test was used. Data are shown as means  S.E.
RESULTS
The tracheal bioelectric properties of newborn mice,
homozygous for a null allele of Tmem16a (referred to as
Tmem16a/ in this study), and their wild-type (/) and
heterozygous (/) littermates are shown in Fig. 1A. There
was no significant difference in the unstimulated short cir-
cuit current (Isc), the response to amiloride, or the residual
(post-amiloride) Isc among the three genotypes. However, a
one-way analysis of variance revealed that the response to
UTP differed significantly (**, p  0.01) among the three
groups. Although the magnitude of the UTP response in the
3 B. R. Grubb, personal communication.
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Tmem16a/ tracheas was significantly reduced when com-
pared with the other two groups, it should be noted that a
significant residual UTP response still remained in the
Tmem16a/ tracheas. The response to forskolin did not
differ among the three genotypes, but the response to
bumetanide was significantly reduced in the Tmem16a/
tracheas when compared with the other two genotypes.
We considered whether the measured bioelectric signals
could have originated in the murine submucosal glands. How-
ever, because no submucosal glands were identified in any tra-
cheal sections examined histologically (18 sections from 9 indi-
vidual tracheas; data not shown) after removal of the tissue
from the Ussing chambers, we concluded that the signal must
originate from the epithelium lining the tracheal lumen.
In an effort to develop a comprehensive understanding of the
proteins involved in the residual UTP-activated response,
mRNA analyses for other TMEM family members in neonatal
tracheal epithelium were conducted (Fig. 1B). Of the TMEM
isoforms carefully evaluated to date, mRNA from Tmem16a,
Tmem16f, and Tmem16k were shown to be expressed in both
proximal and distal tracheal epithelium and mesenchyme.
Thus, these members are candidates for the residual CaCC
activity seen in the Tmem16a/ mice. Other family members,
including Tmem16b and Tmem16j, were not detected in neo-
natal tissue, although Tmem16j was clearly detected in adult
mouse trachea.
The tracheal bioelectric properties of newborn WT and CF
pups are shown in Fig. 1C. The unstimulated Isc was signifi-
cantly reduced in the CF tracheas when compared with WT
tracheas (**, p  0.01), whereas the amiloride response did not
differ between the two genotypes. The post-amiloride residual
Isc was also significantly reduced in the CF tracheas (**, p 
0.01), likely reflecting the reduced unstimulated Isc in these
preparations. The forskolin response in CF tracheas was signif-
icantly reduced (**, p  0.01) when compared with WT. The
response to UTP and bumetanide did not differ between the
genotypes.
Both the Tmem16a/ and the CF tracheas (Fig. 2, B and F)
exhibited anatomical defects in the cartilaginous rings that
appeared similar, with reduced tracheal size when compared
withWT (Fig. 2,A and E). Inmice (bothTmem16a/ andCF),
the cartilaginous rings on the ventral surface were discontinu-
ous, and the epithelial layer exhibited evaginations. However,
the defect was more extensive in the Tmem16a/ tracheas,
extending the entire length of the trachea, whereas in the CF
tracheas, it tended to be confined to the first 3–4 tracheal rings.
There was significant mucus (red-stained neutral mucopo-
lysaccharide) accumulation in the lumen of the Tmem16a/
tracheas, which nearly plugged the trachea in some animals
(Fig. 2D). Most of the mucus was in the lower two-thirds of the
FIGURE 1. Bioelectric and expession patterns of TMEMs and CFTR neona-
tal tracheas. A, tracheal bioelectrics of WT (solid bars, n  7), Tmem16a/
(hatched bars, n  28), and Tmem16a/ pups (open bars, n  7). Unstim.
indicates the unstimulated Isc before drug application. Then, amiloride (Amil)
104 M was added apically, and the magnitude of the resulting change is
shown. The residual Isc is the Isc remaining after amiloride application. Then,
UTP (UTP 104) was added apically followed by apical forskolin (Forsk) 105 M,
and then bumetanide 104 (Bumet) was added basolaterally. The UTP
response differed (**, p  0.01) from the other two groups, *, p  0.05 versus
/ and /. Data are means  S.E. (error bars). B, expression of mRNA from
TMEM isoforms in epithelium and mesenchyme isolated from trachea at post-
natal day 1. Tracheae were separated into sections, RNA was isolated, and
RT-PCR was performed as described under “Experimental Procedures.” Whole
adult trachea and lung were used as positive controls for Tmem16 a, Tmem16f,
Tmem16j, and Tmem16k. For Tmem16b, mouse eye and brain were used
because Tmem16b was not detected in adult trachea or lung (not shown).
Blank  water control; MW  molecular weight marker. Approximate sizes of
products are given (in bp). C, tracheal bioelectrics of WT (solid bars, n  29)
and CF (open bars, n  31) pups. Drug additions and symbols are the same as
in panel A, with the exception that forskolin was added before UTP. **, p 
0.01 from WT. Data are means  S.E (error bars).
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trachea, with little in the mainstem bronchi. The smaller air-
ways were devoid of mucus. The CF tracheas did not contain
any mucus.
DISCUSSION
CaCCs have been implicated in a variety of physiological
functions, including fluid secretion, olfactory transduction
(9–11), and smooth muscle contraction (12). However, until
recently, the molecular identity of these channels has eluded
identification. TMEM16A has now been convincingly identi-
fied as a calcium-activated Cl channel (or a subunit thereof)
with a unique structure but no obvious Ca2 binding sites (3).
A CaCC dominates the Cl secretory response of themurine
trachea, and we have previously speculated that this Cl con-
ductance protects theCFmouse fromCF-like airway disease (1,
13). CaCChas also been demonstrated to be an important func-
tional Cl channel in CF human airway epithelia when CFTR,
the cAMP-mediated Cl channel, is non-functional (14–16).
Gene expression data indicate that the TMEM16A is
expressed at high levels in exocrine glands and in organs rich in
glands (2). In the mouse in vivo, it has been shown that
Tmem16A mediates muscarinic regulated salivary flow, as
intravenous treatment ofmicewithTmem16a small interfering
RNA significantly reduced Tmem16A expression and pilo-
carpine-stimulated salivary flow in submandibular glands (4).
In the present investigation, we studied the function of
Tmem16A in the airways of neonatal pups in which the
Tmem16a gene was deleted (5) and compared these data with
both WT and Cftr gene targeted mice. The unstimulated Isc
reflects components of electrogenic Na absorption and Cl
secretion, and this parameter did not differ among the three
Tmem16a genotypes (/, /, /). The amiloride-sensitive
electrogenicNa absorption also did not differ among the three
genotypes, nor was the amiloride-insensitive residual current,
an index of unstimulated Cl secretion, different between the
three genotypes. Thus, we conclude that Tmem16A does not
contribute to unstimulated Cl secretion, nor does it exhibit a
regulatory relationship to ENaC, as proposed for CFTR (17).
As a probe of regulated Cl secretion in neonatal
Tmem16a/ tracheal preparations, UTP was used as an ago-
nist to increase intracellular calcium, which, in amiloride-pre-
treated tissues, predominantly activates CaCC. We observed a
significant Tmem16a gene dose effect on the magnitude of the
UTP response (Fig. 1A), with Tmem16a/ tracheas exhibiting
a significantly reduced (60%) response when compared with
the WT tissue. However, because a significant UTP response
persisted in the Tmem16a/ tracheas, it is likely that a genet-
ically distinct CaCC also plays a role in the Cl secretory
response of this tissue. A role for Bestrophin 2 in contributing
to CaCC in themurine airway has been suggested by RNA inhi-
bition studies in primary mouse tracheal cells (18). By reducing
Best2 mRNA levels, the authors report a significant reduction
in ATP-stimulated currents to 50% of wild-type levels. In our
study, the magnitude of the forskolin-induced Cl secretory
responses did not differ among the three genotypes, suggesting
thatTMEM16A is not cAMP-regulated. Finally, the response to
bumetanide (which blocks basolateral Cl entry and thus Cl
secretion) was attenuated in the Tmem16a/ tracheas pro-
portionate to the magnitude of the UTP responses in these
tissues.
For CaCC to have its postulated protective role in the CF
mouse lung (1), it must be expressed in the superficial epithe-
lium. Immunohistochemical analysis (4) suggested surface
expression in distal airway epithelium. Our histologic analyses
of the region of the excised neonatal tracheas assayed in Ussing
chambers revealed a well differentiated superficial epithelium
with an absence of glands. Molecular analyses confirmed that
Tmem16a was expressed in this epithelium (Fig. 2B). Thus,
these studies are the first to assign a molecular identity to a
CaCC expressed in murine superficial airway epithelia.
There are several possible candidate CaCCs that mediate the
residual UTP-regulated activity in Tmem16a/ mice. For
example, there are 10 identified genes in theTMEM gene family
inmice and humans, but CaCC function has only been ascribed
to Tmem16a and Tmem16h. Because the Tmem16a/ mice
exhibit residual UTP- (Ca2-) stimulated Cl secretion, levels
of mRNA expression of other TMEM gene family members
were measured in neonatal tracheas (Fig. 2B). Tmem16f and
Tmem16k, but not Tmem16b or Tmem16j, were detected.
FIGURE 2. Histology of WT and mutant tracheas (A, B, E, and F are stained
with hematoxylin and eosin, and C and D are stained with AB-PAS). A, WT
(littermate to B). In the normal trachea, the cartilage is continuous except
along the posterior membrane (at the top of the figure), giving the normal
trachea a rounded appearance (see also C and E). Due to the plane of section,
the cartilage can appear discontinuous in the WT tissue (as in C).
B, Tmem16a/ trachea exhibiting cartilaginous defects on the ventral (bot-
tom of figure) side. Evaginations of the epithelial layer are evident, and the
normal rounded appearance of the lumen is lost. C, WT trachea stained with
AB-PAS. D, Tmem16a/ trachea stained with AB-PAS exhibiting significant
lumenal mucus accumulation. E, trachea of WT (littermate to F). F, CF trachea
exhibits a cartilaginous defect on the ventral side that results in discontinu-
ous cartilaginous rings. Epithelial evaginations are also evident. All were pho-
tographed at same magnification; see scale in F.
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Alternatively, future studies are required to assign residual
CaCC function to the protein products of TMEM gene family
members or other genes.
As one approach to determine the relative roles of
TMEM16A versusCFTR in neonatal tracheal Cl secretion, we
studiedCFmouse tracheas also excised 12–24 h after birth. The
neonatal CF tracheas exhibited a significant reduction in the
unstimulated Isc when compared with WT, suggesting that a
portion of this Cl secretion is mediated via CFTR (50%). As
reported for adult CF mice (13), there was no difference in the
amiloride response between the two genotypes. Unlike the
Tmem16a/ tracheas, the tracheas from the CF pups exhib-
ited a significant decrease in the post-amiloride residual Isc,
supporting the notion that the post-amiloride residual Isc
reflects Cl secretion. Note that because a significant post-
amiloride Isc remained in the CF tracheas, it is possible that a
CaCC (but probably not TMEM16A, as this residual Isc is not
reduced in Tmem16a/ mice) is responsible for the residual
Isc. With respect to regulated Cl secretion, the pattern in the
CFmouse was the inverse of the TMEM16Amutantmouse, i.e.
forskolin-stimulated Isc was small in WT mice but reduced
more than 75% inCFmice, whereasUTP-stimulatedCl secre-
tionwas large andunaffected byCFTR gene targeting.Note that
in the adult CF mouse, there is no defect in either the unstimu-
lated Isc or the residual Isc, suggesting that CFTR function
wanes with age (13).
Interestingly, in mice in which either the cAMP-mediated
Cl channel (Cftr gene) or the calcium-mediated Cl channel
(Tmem16a gene) was deleted, a similar congenital defect in the
tracheal cartilage was observed (5, 8, 19). In mice with either
mutation, this defect involves the cartilaginous rings on the
ventral surface of the trachea. In the Tmem16a/ pups, the
cartilaginous rings were discontinuous along the entire length
of the trachea. This phenotype, which extends into the main-
stem bronchi, was 100% penetrant in the Tmem16a mutant
pups (5). This cartilaginous defect was also present in both the
CFTR null mutation (cftrtm1unc) and the F 508 CFTR muta-
tions (cftrtm1kth) at a frequency of occurrence ranging from 86
to 100% (8). However, in the cftrtm1uncmutation, the defect was
confined to the upper trachea, whereas in the cftrtm1kth mice,
the defect was present all along the trachea (8). Because the two
CF mouse models studied were on different genetic back-
grounds, the difference in phenotypic expression of the tracheal
malformation may be a strain-dependent phenomenon (8).
Two quite different hypotheses may describe the molecular
mechanisms producing the similar morphologic findings in
mice with different genetic mutations. First, it is possible that
both CFTR and TMEM16A expression in mesenchymal struc-
tures, e.g. tracheal smooth muscle, are important for cartilage
development. Both CFTR (20) and TMEM16A (5) have been
reported to be expressed in tracheal smooth muscle, and we
observed expression of TMEM16A in themesenchyme isolated
from neonatal tracheal tissue (Fig. 1B). Second, it is possible
that the defects reflect a reduction in Cl (and liquid) secretion
into the fetal lung. A reduction in both basal (CFTR) and Ca2-
regulated (TMEM16A) Cl secretion is predicted to reduce
fetal lung liquid secretion and decrease pulmonary transmural
pressure gradients. Transmural pressure gradients are impor-
tant stimuli for lung growth, perhaps including tracheal
cartilage.
The presence of mucus (neutral mucopolysaccharide red-
stained material in AB-PAS-stained sections) in the lumen of
the Tmem16a/ tracheas was striking and not previously
reported by Rock et al. (5), possibly due to differences in fixa-
tion techniques. A similar accumulation of mucus in the tra-
chea has been observed in a mouse model of ASL depletion
caused by transgenic overexpression of ENaC (21). Based on
this comparison, we speculate that the mucus accumulation
reflects a defect in CaCC-mediated Cl secretion and conse-
quent ASL depletion.
However, no mucus was observed in the CF tracheas.
Although the CF neonatal tracheas exhibit a reduction in the
unstimulated secretion by50% and a greater than 75% reduc-
tion in the cAMP-stimulated response, the absolute magni-
tudes of these reductions in Cl secretion were small (10 and 6
Acm2, respectively), likely too small to reduce ASL volume
and produce a reduction in mucus clearance sufficient to pro-
duce mucus accumulation. In contrast, in the Tmem16a/
tracheas, the basal Cl secretory rate appeared normal, but the
reduction in stimulated Cl secretion via CaCC (TMEM16A)
was large (40 Acm2). We speculate that it is the large,
regulated component of Cl secretion that is necessary to
maintainASLhydration sufficient for adequateMCC inmurine
airways.
The identification of both cartilaginous defects and intralu-
menalmucus accumulation have led us to re-evaluate themode
of early death of Tmem16a/ mice (5). The cartilaginous
defects were extensive in the Tmem16a/ tracheas and pro-
duced increased compliance that resulted in collapse of
Tmem16a/ tracheas with the slightest pressure. Morpho-
metric indications of this “floppiness” were noted in the fixed
tracheas of Tmem16a/ mice (Fig. 2B). We speculate that
pressure-induced collapse of tracheas caused intralumenal
mucus-mediated adhesion of opposing tracheal walls to occur,
resulting in acute asphyxia in most neonates (90% of the pups
die by day 9 (5)). The reported presence of air in the esophagus
and stomach (5) likely is a result of gasping secondary to
asphyxia.
In conclusion, we have shown that Tmem16a encodes for the
dominant CaCC activity in the superficial epithelium of neonatal
murine airways. Based on the accumulation of mucus in airways
likely due to deficient Cl and liquid secretion, and perhaps the
relative magnitude of the cartilaginous defects in Tmem16a/
tracheas, TMEM16A, not CFTR, appears to be the dominant Cl
channel inmouse airways.Wespeculate thatmaneuvers to extend
the life ofTmem16a/mice and/or generationof airway-specific
Tmem16a conditional nullmicewill produce amouse lungmodel
of CF-like defective Cl and liquid secretion, intrapulmonary
mucus stasis, inflammation, and death.
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